About Caris & Company

Recent News

  • Jan 3, 2012
    Caris & Company appoints Brian A. Miller as Managing Director: Institutional Equity Sales
    Read More
  • Dec 5, 2011
    Caris & Company appoints Kevin P. Cushing as Managing Director: Institutional Equity Sales
    Read More
  • Dec 1, 2011
    Caris & Company appoints Thomas P. Rorke as Managing Director: Institutional Equity Sales
    Read More
  • Sep 12, 2011
    Caris & Company appoints Gabriele Sorbara Vice President of Energy Equity Research: Exploration and Production
    Read More

Caris News

January 3, 2012:
Caris & Company appoints Brian A. Miller as Managing Director: Institutional Equity Sales

December 5, 2011:
Caris & Company appoints Kevin P. Cushing as Managing Director: Institutional Equity Sales

December 1, 2011:
Caris & Company appoints Thomas P. Rorke as Managing Director: Institutional Equity Sales

September 12, 2011:
Caris & Company appoints Gabriele Sorbara Vice President of Energy Equity Research: Exploration and Production

May 27, 2011:
Caris & Company participates in Solazyme's Initial Public Offering

May 27, 2011:
Caris & Company participates in MakeMyTrip's Follow-On Offering

May 25, 2011:
Caris & Company Receives Six Starmine Awards

April 6, 2011:
Caris & Company Launches Coverage on Utilities Sector

March 31, 2011:
Caris & Company Launches Coverage on Orthopedics Sector

March 30, 2011:
Caris Launches Coverage of 8 Hardlines Names in the Consumer Electronics and Office Supply Sectors

March 25, 2011:
Caris & Company Acts as US Placement Agent in Phylogica's Capital Raise

March 14, 2011:
Caris & Company appoints Mark Durkin Managing Director: New York Institutional Sales

March 9, 2011:
Caris & Company participates in HCA's Initial Public Offering

March 9, 2011:
Caris & Company Appoints Elizabeth E. Kadin as Managing Director: Institutional Equity Sales

March 3, 2011:
Caris & Company and MM Dillon form Joint Venture

March 1, 2011:
Caris & Company appoints Scott Tilghman as Managing Director: Consumer Equity Research

February 10, 2011:
Caris & Company acts as Co-Manager in Kips Bay Initial Public Offering

January 17, 2011:
Jason Wittes Joins Caris & Company as Managing Director: Medical Device Research

January 17, 2011:
Caris & Company appoints Dan Ferry Senior Vice President: Boston Institutional Sales

December 9, 2010:
Caris & Company acts as Co-Manager in SemiLEDs Initial Public Offering

November 29, 2010:
Caris & Company appoints Nathan Estep Senior Vice President: New York Instituitonal Sales

November 29, 2010:
Caris & Company appoints Robert McLaughlin as Managing Director: Boston Sales Trading

November 10, 2010:
Caris & Company acts as Co-Manager in RDA Microelectronics Initial Public Offering

July 12, 2010:
Caris & Company promotes Craig A. Ellis to Director of Research and Senior Managing Director

June 14, 2010:
Caris & Company appoints Jamie Ryan Pennington as Managing Director: Institutional Equity Sales - Texas

May 28, 2010:
Caris & Company acts as Underwriter in Salix Pharmaceuticals $300,000,000 Convertible debt transaction

May 2, 2010:
Caris & Company appoints Mario Corso Managing Director: Specialty Pharma & Biopharma Equity Research

May 3, 2010:
Caris & Company acts as advisor to AdventRX in $19.2 Million Convertable Preferred Stock Offering

April 29, 2010:
Caris & Company acts as Co-Manager in Alpha and Omega Semiconductors $91 million IPO

March 15, 2010:
Caris & Company Receives 2009 Best of Business Award

March 25, 2010:
Caris & Company participates in Netlogic's $180 million secondary offering

December 8, 2009:
Caris & Company acts as Co-Placement agent for Wilex's EUR 8.9 Million Public Equity Offering

November 2, 2009:
Caris & Company appoints Matt Winer Managing Director: Midwest Institutional Sales

March 25, 2009:
Caris & Company acts as co-placement agent for PharmAthene's $5.5 Million Public Equity Offering

March 22, 2009:
Caris & Company appoints Craig A. Ellis Head of Technology Research

March 22, 2009:
Caris & Company appoints Dorothy Lakner Managing Director: Specialty Retail Research

January 26, 2009:
Caris & Company appoints Sheilah McFadden as Vice President: Mid-Atlantic Institutional Sales

September 8, 2008:
Caris & Company appoints Curtis Shauger Senior Vice President: Technology Research-Software

July 8, 2008:
Caris & Company appoints David Miller Managing Director: Media & Entertainment Equity Research

June 30, 2008:
Caris & Company appoints Tony Kiniry Head of Equity Sales Trading

March 31, 2008:
Caris & Company appoints Linda Bolton-Weiser Managing Director: Consumer Equity Research

December 10, 2007:
Underground Solutions, Inc. (Ticker:UGSI)-Caris & Company acts as Financial Advisor for Private Placement

August 20, 2007:
Caris & Company appoints Leo Carpio as Vice President: HCIT Research

August 16, 2007:
Caris & Company appoints Jonathan Meyers as Head of Technology Investment Banking

June 27, 2007:
Caris & Company appoints Mike Gilman as Managing Director: West Coast Institutional Sales

June 18, 2007:
Caris & Company appoints Dr. Kenneth Rind Advisor: Health Care & Technology Investment Banking

June 5, 2007:
Caris & Company Co-Manages 3 Million Share IPO for Response Genetics.

May 29, 2007:
Caris & Company Co-Manages $99.4 Million Follow-on Offering for Omnicell, Inc.

March 26, 2007:
Caris & Company hires Ben Pang as Senior Vice President of Semiconductor Capital Equipment Research.

January 5, 2007:
Caris & Company Co-Manages Capital Raise for Canadian Biotech

November 27, 2006:
Caris & Company rated top research boutique by Motley Fool.

Most Recent Research

Questcor

(QCOR)


2/03/2012

TECO Energy

(TE)


2/03/2012

Alkermes

(ALKS)


2/03/2012

Healthcare IT

2/03/2012

TiVO Inc.

(TIVO)


2/03/2012

Sally Beauty

(SBH)


2/03/2012